Evidence map›Paper›PMID 39629563›Full record

ArticleClinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery2025

Epidemiology of Cholesteatoma in the UK Biobank.

Emma Wilson, Barbara Anne Jennings, Mizanur Khondoker, Carl M Philpott, Peter Prinsley, Daniel S Brewer

Abstract read
In one paragraph

Article in Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. The Global Burden of Cholesteatoma: A Systematic Review and Meta-analysis.Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2026
    Pooled it
  2. Middle ear cholesteatoma: biological basis, invasiveness heterogeneity, and challenges in severity assessment.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Sociodemographic Factors Influencing Operative Time and Extent of Surgery in the Management of Cholesteatoma.Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Emma WilsonNorwich Medical School, University of East Anglia, Norwich, UK.
Barbara Anne JenningsNorwich Medical School, University of East Anglia, Norwich, UK.ORCID 0000-0003-3792-9182
Mizanur KhondokerNorwich Medical School, University of East Anglia, Norwich, UK.ORCID 0000-0002-1801-1635
Carl M PhilpottENT Department, James Paget University Hospitals NHS Foundation Trust, Great Yarmouth, Norfolk, UK.ORCID 0000-0002-1125-3236
Peter PrinsleyNorwich and Norfolk University Hospital, Norfolk, UK.
Daniel S BrewerNorwich Medical School, University of East Anglia, Norwich, UK.ORCID 0000-0003-4753-9794

Funding

Bernice Bibby Research TrustUniversity of East Anglia Faculty of Medicine and Health Sciences
6 · The paper itself

Abstract

objectivesTo identify factors associated with cholesteatoma in a large UK cohort. Although some risk factors are frequently reported (male sex, history of chronic otitis media), other associations require further evidence (deprivation, smoking). DESIGN AND

settingBriefly, 1140 cholesteatoma cases from UK BioBank were compared to 4551 non-cholesteatoma middle ear disease and 493 832 ear disease-free controls. Adjusted odds ratios were calculated for demographic factors including age, sex, ethnicity, deprivation and smoking status with logistic regressions. Odds ratios for overlapping ICD-10 codes are also calculated.

resultsCholesteatoma was significantly associated with sex (Adjusted odds ratio (AOR) for males = 1.33, 95%CI = [1.179-1.491]), age (AOR = 1.02, 95%CI = [1.011-1.026]) and deprivation (AOR = 1.08, 95%CI = [1.059-1.097]) compared to ear disease-free controls (p < 0.001). Age and deprivation distributions for cholesteatoma and non-cholesteatoma ear disease were similar. Although there was no significant association with smoking status, cholesteatoma was significantly associated with the ICD-10 code mental and behavioural disorders due to tobacco use (OR = 2.34, p < 0.001, 95%CI = [1.942, 2.813]). Cholesteatoma was also strongly associated with a wide range of inflammatory middle ear conditions and chronic sinus inflammation, suggesting an increased susceptibility to inflammation of the upper airways.

conclusionThis study shows a large overlap between cholesteatoma and non-cholesteatoma ear disease in terms of numbers and demographics, with sex being a key factor distinguishing between the two, suggesting that there are both common and distinct associated factors.

Indexed as

Cholesteatoma, Middle EarAdultAgedBiological Specimen BanksCase-Control StudiesFemaleHumansMaleMiddle AgedRisk FactorsUK BiobankUnited Kingdomcholesteatomaepidemiologyhearing lossmiddle earotitis media

Identifiers

PMID39629563
PMCPMC11792432

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.